When compared to the review of Maisonneuve and Lowenfels from 2015, 52 new risk factors have been identified that have been investigated in systematic reviews or meta-analyses to assess their association with pancreatic cancer, including autoimmune liver disease, BRCA gene mutation, co-infection with hepatitis B and C, and insulin use. This evidence concerns the gene INS and familial pancreatic carcinoma.